<!-- received="Wed Jan 28 05:36:23 1998 MDT" -->
<!-- sent="Wed, 28 Jan 1998 07:36:20 -0500 (EST)" -->
<!-- name="Technotranscendence" -->
<!-- email="neptune@mars.superlink.net" -->
<!-- subject="Re: BHT" -->
<!-- id="199801281236.HAA21645@mars.superlink.net" -->
<!-- inreplyto="BHT" -->
<title>extropians: Re: BHT</title>
<h1>Re: BHT</h1>
Technotranscendence (<i>neptune@mars.superlink.net</i>)<br>
<i>Wed, 28 Jan 1998 07:36:20 -0500 (EST)</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#1237">[ date ]</a><a href="index.html#1237">[ thread ]</a><a href="subject.html#1237">[ subject ]</a><a href="author.html#1237">[ author ]</a>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<li> <b>Previous message:</b> <a href="1236.html">Charlie Stross: "Re: Topics of current personal interest"</a>
<li> <b>Maybe in reply to:</b> <a href="1204.html">Anders Sandberg: "BHT"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<li> <b>Reply:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<!-- reply="end" -->
</ul>
<hr>
<!-- body="start" -->
At 07:54 PM 1/27/98 +0100, Anders Sandberg &lt;asa@nada.kth.se&gt; wrote:<br>
<i>&gt;Hmm, I got interested and did a small medline search. While most of</i><br>
<i>&gt;the stuff tends to support your claims, I also found the article</i><br>
<i>&gt;abstracted below, which suggests that BHT may not be as great as</i><br>
<i>&gt;Pearson &amp; Shaw claim due to carcinogenic properties.</i><br>
<p>
I wish Pearson and Shaw would write a second edition of the _Life<br>
Extension_ book, updating it with all the research that has gone on<br>
in the last few years.<br>
<p>
<i>&gt;Z Lebensm Unters Forsch 1993 Apr;196(4):329-338 </i><br>
<i>&gt;</i><br>
<i>&gt;[Toxicology of the synthetic antioxidants BHA and BHT in</i><br>
<i>&gt;comparison with the natural antioxidant vitamin E].</i><br>
<i>&gt;</i><br>
<i>&gt;Kahl R, Kappus H</i><br>
<i>&gt;Abteilung fur Pharmakologie, Universitat Hamburg, Deutschland. </i><br>
<i>&gt;</i><br>
<i>&gt;The toxicology of the food preservatives butylhydroxyanisole (BHA) and</i><br>
<i>&gt;butylhydroxytoluene (BHT) as well as the naturally occurring vitamin E</i><br>
<i>&gt;(alpha-tocopherol) is described. In high dosages all three compounds</i><br>
<i>&gt;induce in animals impairment of blood clotting, which can be explained</i><br>
<i>&gt;by an antagonism with vitamin K. Specific toxic effects to the lung</i><br>
<i>&gt;have only been observed with BHT. The other described toxic effects of</i><br>
<i>&gt;BHA and BHT are less characteristic and often occur only after high</i><br>
<i>&gt;dosage and long-term treatment. However, BHA induces in animals</i><br>
<i>&gt;tumours of the forestomach, which are dose dependent, whereas BHT</i><br>
<i>&gt;induces liver tumours in long-term experiments. Because there is no</i><br>
<i>&gt;indication of genotoxicity of BHA and BHT, all published findings</i><br>
<i>&gt;agree with the fact that BHA and BHT are tumour promoters. In contrast</i><br>
<i>&gt;to BHA and BHT, vitamin E is not carcinogenic. On the other hand, all</i><br>
<i>&gt;three antioxidants have also anticarcinogenic properties. The intake</i><br>
<i>&gt;of the necessary high doses as for these effects are, however,</i><br>
<i>&gt;contraindicated with BHA and BHT because of their carcinogenic</i><br>
<i>&gt;effects. The present overview concludes that the concentrations of BHA</i><br>
<i>&gt;and BHT nowadays used in food, drugs and cosmetics are probably</i><br>
<i>&gt;harmless. In addition, vitamin E can also be used in higher doses</i><br>
<i>&gt;without the occurrence of adverse effects.</i><br>
<p>
What is a high dose and what is long term?<br>
<p>
I hate when reports don't specify amounts or ranges.  This is the<br>
same with "moderate drinking."  What exactly is "moderate"?<br>
<p>
Daniel Ust<br>
<!-- body="end" -->
<hr>
<p>
<ul>
<!-- next="start" -->
<li> <b>Next message:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<li> <b>Previous message:</b> <a href="1236.html">Charlie Stross: "Re: Topics of current personal interest"</a>
<li> <b>Maybe in reply to:</b> <a href="1204.html">Anders Sandberg: "BHT"</a>
<!-- nextthread="start" -->
<li> <b>Next in thread:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<li> <b>Reply:</b> <a href="1238.html">Anders Sandberg: "Re: BHT"</a>
<!-- reply="end" -->
</ul>
